Citi Turns Bullish on Marvell Ahead of CES
Citi sees Marvell’s post-earnings dip as a buying chance, driven by AI data centers and strong growth outlook for 2026–2027.
Already have an account? Sign in.
Citi sees Marvell’s post-earnings dip as a buying chance, driven by AI data centers and strong growth outlook for 2026–2027.
Eli Lilly plans to buy Kelonia Therapeutics for $2B+. The deal would boost Lilly’s cancer business and reduce reliance on weight-loss drugs.
Google is in talks with Marvell Technology to develop a new memory processing unit and an inference-optimized TPU to power its AI models more efficiently.
The deal is expected to close in Q3 2026 and immediately boost earnings.